Chatzopoulos GS,
Doufexi AE, Kalogirou F. Association of
susceptible genotypes to
periodontal disease with the clinical outcome
and tooth survival after non-surgical periodontal therapy: A
systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21
(1):e14-29.
doi:10.4317/medoral.20638
http://dx.doi.org/doi:10.4317/medoral.20638
|
1. Lopez R, Baelum V. Classifying periodontitis among
adolescents: implications
for epidemiological research. Community Dent Oral Epidemiol.
2003;31:136-43. |
|
|
|
|
|
2.
Page RC, Kornman KS. The pathogenesis of human periodontitis: an
introduction. Periodontol
2000. 1997;14:9-11. |
|
|
|
|
|
3. Stabholz A, Soskolne WA, Shapira L. Genetic and environmental risk factors for chronic
periodontitis and aggressive periodontitis. Periodontol 2000. 2010;53:138-53. |
|
|
|
|
|
4.
Johnson NW, Griffiths GS, Wilton
JM, Maiden MF, Curtis MA, Gillett
IR, et al. Detection of high-risk
groups and individuals for periodontal diseases. Evidence for the existence of high-risk groups and individuals and approaches to their detection.
J Clin Periodontol.
1988;15:276-82. |
|
|
|
|
|
5. Loos BG, John RP, Laine ML. Identification of genetic risk factors for periodontitis and possible mechanisms of action. J Clin Periodontol. 2005;32(Suppl. 6):159-79. |
|
|
|
|
|
6. Hart TC. Genetic considerations of risk in human
periodontal disease. Curr
Opin Periodontol.
1994;3-11. |
|
|
|
|
|
7. Michalowicz BS, Aeppli D, Virag JG, Klump DG, Hinrichs JE, Segal NL, et al.
Periodontal findings in adult
twins. J Periodontol.
1991;62:293-9. |
|
|
|
|
|
8. Sofaer JA. Genetic approaches in the study of periodontal diseases.
J Clin Periodontol.
1990;17:401-8. |
|
|
|
|
|
9. Yoshie H, Kobayashi T, Tai H, Galicia JC. The role of genetic polymorphisms in
periodontitis. Periodontol 2000. 2007;43:102-32. |
|
|
|
|
|
10. Kornman KS, Crane A, Wang HY,
di Giovine FS, Newman MG,
Pirk FW, et al. The
interleukin-1 genotype as a severity
factor in adult periodontal disease.
J Clin Periodontol.
1997;24:72-7. |
|
|
|
|
|
11. McDevitt MJ, Wang HY, Knobelman
C, Newman MG, di Giovine
FS, Timms J, et al. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol. 2000;71:156-63. |
|
|
|
|
|
12. Shapira L, van Dyke TE, Hart TC. A localized absence of interleukin-4 triggers
periodontal disease activity:
a novel hypothesis. Med Hypotheses. 1992;39:319-22. |
|
|
|
|
|
13. Anovazzi G, Kim YJ, Viana AC, Curtis KM, Orrico SR, Cirelli JA, et al. Polymorphisms and haplotypes in
the interleukin-4 gene are associated
with chronic
periodontitis in a Brazilian population.
J Periodontol. 2010;81:392-402. |
|
|
|
|
|
14.
Leonard EJ, Yoshimura T. Neutrophil
attractant/activation
protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol. 1990;2:479-86. |
|
|
|
|
|
15. Scarel-Caminaga RM, Kim YJ, Viana AC, Curtis KM, Corbi SC, Sogumo PM, et al. Haplotypes in the interleukin 8 gene and their association with chronic periodontitis susceptibility.
Biochem Genet.
2011;49:292-302. |
|
|
|
|
|
16. Andia DC, de Oliveira NF, Letra AM, Nociti
FH Jr, Line SR, de Souza AP. Interleukin-8 gene promoter polymorphism (rs4073) may contribute to chronic periodontitis. J Periodontol. 2011;82:893-9. |
|
|
|
|
|
17. Sorsa T, Tjderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004;10:311-8. |
|
|
|
|
|
18. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen. 1999;7:423-32. |
|
|
|
|
|
19. Sapna G, Gokul S, Bagri-Manjrekar K. Matrix metalloproteinases and periodontal diseases.
Oral Dis. 2014;20:538-50. |
|
|
|
|
|
20. Hou T, Gao L, Zheng J, Liu Z, Wu C, Liu Q, et al. Matrix metalloproteinase-1 gene polymorphisms
and periodontitis susceptibility: a meta-analysis based on 11 case-control studies.
Gene. 2013;521:111-5. |
|
|
|
|
|
21. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility
to infectious diseases. Clin Infect Dis. 2003;37:1496-505. |
|
|
|
|
|
22. Ozaka O, Biakci N, Nalbantsoy A, Kse T, Berdeli A. Association between mannose-binding lectin levels and gene polymorphisms in chronic
periodontitis and response to treatment.
Arch Oral Biol. 2010;55:235-41. |
|
|
|
|
|
23. Furlan AD, Pennick V, Bombardier C, van Tulder M.
Editorial Board, Cochrane Back Review
Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976). 2009;34:1929-41. |
|
|
|
|
|
24. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol.
2009;62:1006-12. |
|
|
|
|
|
25.
Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, et al. Association
between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis.
2008;25:539-47. |
|
|
|
|
|
26. Chambrone L, Preshaw PM, Rosa
EF, Heasman PA, Romito GA, Pannuti
CM, et al. Effects of smoking cessation
on the outcomes of non-surgical
periodontal therapy: a systematic
review and individual patient
data meta-analysis. J Clin
Periodontol. 2013;40:607-15. |
|
|
|
|
|
27.
Hozo SP, Djulbegovic B, Hozo I. Estimating
the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. |
|
|
|
|
|
28. Lang NP, Tonetti MS, Suter J, Sorrell J, Duff GW, Kornman KS. Effect of interleukin-1 gene polymorphisms
on gingival inflammation assessed by bleeding
on probing in a
periodontal maintenance population.
J Periodontal Res. 2000;35:102-7. |
|
|
|
|
|
29. Cattabriga M, Rotundo R, Muzzi
L, Nieri M, Verrocchi G,
Cairo F, et al. Retrospective evaluation
of the influence of the interleukin-1 genotype on radiographic bone levels in treated periodontal patients over 10 years. J Periodontol. 2001;72:767-73. |
|
|
|
|
|
30. Bumer A, El Sayed N, Kim TS, Reitmeir P, Eickholz P, Pretzl B. Patient-related risk factors for tooth loss
in aggressive periodontitis after
active periodontal therapy. J Clin
Periodontol. 2011;38:347-54. |
|
|
|
|
|
31. Nieri M, Muzzi L, Cattabriga M, Rotundo R, Cairo F, Pini
Prato GP. The prognostic value of several periodontal factors measured as radiographic bone level variation:
a 10-year retrospective multilevel
analysis of treated and maintained periodontal patients.
J Periodontol. 2002;73:1485-93. |
|
|
|
|
|
32. Persson GR, Matulien G, Ramseier CA, Persson RE, Tonetti MS, Lang NP. Influence of interleukin-1 gene polymorphism
on the outcome of supportive
periodontal therapy explored
by a multi-factorial
periodontal risk assessment
model (PRA). Oral Health Prev Dent. 2003;1:17-27. |
|
|
|
|
|
33. Knig J, Rhling A, Plagmann HC, Meisel P, Kocher T. Influence of interleukin (IL)-1 composite genotype on clinical
variables in non-smoking, well-maintained compliant patients with chronic periodontitis. Swed Dent J. 2005;29:11-6. |
|
|
|
|
|
34. Muzzi L, Nieri M, Cattabriga M, Rotundo R, Cairo F, Pini
Prato GP. The potential prognostic value of some periodontal factors for tooth
loss: a retrospective multilevel analysis on periodontal patients treated and maintained over 10 years. J Periodontol. 2006;77:2084-9. |
|
|
|
|
|
35.
Wolf DL, Neiderud AM, Hinckley
K, Dahln G, van de Winkel
JG, Papapanou PN. Fcgamma
receptor polymorphisms and periodontal status: a prospective follow-up study. J Clin Periodontol. 2006;33:691-8. |
|
|
|
|
|
36. Eickholz P, Kaltschmitt J, Berbig J, Reitmeir P, Pretzl B. Tooth loss after active periodontal therapy. 1: patient-related factors for risk,
prognosis, and quality of outcome.
J Clin Periodontol.
2008;35:165-74. |
|
|
|
|
|
37. Nibali L, Pelekos G, D'Aiuto F, Chaudhary N, Habeeb R, Ready D, et al. Influence of IL-6 haplotypes on clinical and inflammatory response in aggressive
periodontitis. Clin Oral Investig.
2013;17:1235-42. |
|
|
|
|
|
38. Ehmke B, Kress W, Karch H, Grimm T, Klaiber B, Flemmig TF. Interleukin-1 haplotype
and periodontal disease progression
following therapy. J Clin Periodontol.
1999;26:810-3. |
|
|
|
|
|
39. Jeffcoat MK, Jeffcoat RL, Tanna N, Parry SH. Association of a common genetic factor, PTGER3, with outcome of periodontal therapy
and preterm birth. J Periodontol. 2014;85:446-54. |
|
|
|
|
|
40. Emingil G, Han B, Grkan A, Berdeli A, Tervahartiala T,
Salo T, et al. Matrix metalloproteinase
(MMP)-8 and tissue inhibitor
of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive
periodontitis: gingival crevicular fluid MMP-8 and
TIMP-1 levels and outcome
of periodontal therapy. J Periodontol.
2014;85:1070-80. |
|
|
|
|
|
41. Anovazzi G, Finoti LS, Corbi SC, Kim YJ, Marcaccini
AM, Gerlach RF, et al. Interleukin
4 haplotypes of susceptibility
to chronic periodontitis
are associated with IL-4 protein levels but not with
clinical outcomes of
periodontal therapy. Hum Immunol. 2013;74:1688-95. |
|
|
|
|
|
42. Finoti LS, Anovazzi G, Pigossi SC, Corbi SC, Teixeira
SR, Braido GV, et al. Periodontopathogens
levels and clinical
response to periodontal therapy
in individuals with the interleukin-4 haplotype associated with susceptibility to chronic periodontitis. Eur J Clin Microbiol Infect Dis. 2013;32:1501-9. |
|
|
|
|
|
43. Finoti LS, Corbi SC, Anovazzi G, Teixeira SR, Capela MV, Tanaka
MH, et al. Pathogen levels
and clinical response to
periodontal treatment in patients
with Interleukin 8 haplotypes. Pathog Dis. 2013 Jul 2 [Epub ahead of print]. |
|
|
|
|
|
44. Pirhan D, Atilla G, Emingil G, Sorsa T, Tervahartiala T, Berdeli A. Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of
periodontal therapy in patients
with severe chronic periodontitis. J Clin Periodontol. 2008;35:862-70. |
|
|
|
|
|
45. Pirhan D, Atilla G, Emingil G, Tervahartiala T, Sorsa T, Berdeli A. MMP-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF MMP-13 levels and outcome of periodontal therapy.
J Clin Periodontol.
2009;36:474-81. |
|
|
|
|
|
46. Corbi SC, Finoti LS, Anovazzi G, Tanaka MH, Kim YJ, Secolin R, et al. Clinical outcomes of periodontal therapy
are not influenced by the ATC/TTC haplotype in the IL8 gene. J Periodontol Res. 2014;49:489-98. |
|
|
|
|
|
47. D'Aiuto F, Ready D, Parkar M, Tonetti MS. Relative contribution of patient-, tooth-, and site-associated variability on the clinical
outcomes of subgingival debridement. I. Probing depths. J Periodontol.
2005;76:398-405. |
|
|
|
|
|
48. Yoshie H, Tai H, Kobayashi T, Oda-Gou E, Nomura Y, Numabe Y, et al. Salivary enzyme levels after scaling and interleukin-1 genotypes
in Japanese patients with chronic periodontitis. J Periodontol. 2007;78:498-503. |
|
|
|
|
|
49. McGuire MK, Nunn ME. Prognosis
versus actual outcome. IV. The
effectiveness of clinical
parameters and IL-1 genotype
in accurately predicting prognoses and tooth survival. J Periodontol.
1999;70:49-56. |
|
|
|
|
|
50. Huynh-Ba G, Lang NP, Tonetti MS, Salvi GE. The association of the composite IL-1 genotype with periodontitis progression and/or treatment outcomes: a systematic review. J Clin Periodontol.
2007;34:305-17. |
|
|
|
|
|
51.
Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin
8 gene region in UK families.
Thorax. 2000;55:1023-7. |
|
|
|
|
|
52. Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, et al. Molecular basis
of opsonic defect in immunodeficient children. Lancet. 1991;337:1569-70. |
|
|
|
|
|
53.
Wallis R, Cheng JY. Molecular defects
in variant forms of mannose-binding protein associated with immunodeficiency. J Immunol.
1999;163:4953-9. |
|
|
|
|
|
54. Lyons JG, Birkedal-Hansen B,
Moore WG, O'Grady RL, Birkedal-Hansen
H. Characteristics of a 95-kDa matrix
metalloproteinase produced
by mammary carcinoma cells. Biochemistry.
1991;30:1449-56. |
|
|
|
|
|
55. DeClerck YA, Yean TD, Lu HS, Ting J, Langley KE. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J Biol Chem. 1991;266:3893-9. |
|
|
|
|
|
56.
Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human
72-kDa progelatinase by tissue inhibitor of
metalloproteinases-2. J Biol Chem.
1991;266:13064-9. |
|
|
|
|
|
57. Rutter JL, Mitchell TI, Buttic
G, Meyers J, Gusella JF, Ozelius LJ, et al. A single nucleotide
polymorphism in the matrix metalloproteinase-1 promoter
creates an Ets binding site
and augments transcription.
Cancer Res. 1998;58:5321-5. |
|
|
|
|
|
58. Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y, et al. Association between IL-4 genotype and IL-4 production in
the Japanese population. Genes Immun.
2002;3:107-9. |
|
|
|
|
|
59. Shirodaria S, Smith J, McKay
IJ, Kennett CN, Hughes FJ. Polymorphisms
in the IL-1A gene are correlated
with levels of
interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res.
2000;79:1864-9. |
|
|
|
|
|
60. Armitage GC, Wu Y, Wang HY, Sorrell J, Giovine FS, Duff GW. Low prevalence of a periodontitis-associated
interleukin-1 composite genotype
in individuals of Chinese
herritage. J Periodontol.
2000;71:164-71. |
|
|
|
|
|
61. Brgido JA, da Silveira VR, Rego RO, Nogueira NA. Serotypes of Aggregatibacter actinomycetemcomitans in relation
to periodontal status and geographic
origin of individuals-a review of the literature. Med Oral Patol Oral
Cir Bucal. 2014;19:e184-91. |
|
|
|
|
|
62. Hart TC, Ferrell RE. Genetic testing considerations for oral
medicine. J Dent Educ.
2002;66:1185-202. |
|
|
|
|
|
63. Garcia I, Tabak LA. A view of the future:
dentistry and oral health
in America. J Am Dent Assoc. 2009;140 (Suppl
1):44S-8S. |
|
|
|
|
|
64. Hayden JA, van der Windt DA, Cartwright JL, Ct P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280-6. |
|